In March 2026, topline results from the TRANSCEND-T2D-1 trials showed that participants with Type 2 diabetes achieved an average A1C reduction of up to 2.0% and lost nearly 17% of their body weight over 40 weeks
You wont be handed a brochure and sent on your way, youll be guided by a professional who listens, tracks progress and adjusts your plan in real time
Journal of Hematology and Oncology 15(1):23, 2022
Our Glutathione Serum is an antioxidant-enriched serum that leaves skin with a youthful, hydrated, radiant, and more even complexion
Its long-acting design extends receptor engagement compared to native amylin
The active medication in Ozempic is semaglutide, which belongs to a class of drugs called glucagon-like peptide-1 receptor agonists, or GLP-1s